EBRGD Trademark

Trademark Overview

On Tuesday, May 18, 2021, a trademark application was filed for EBRGD with the United States Patent and Trademark Office. The USPTO has given the EBRGD trademark a serial number of 90718261. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 14, 2023. This trademark is owned by Molecular Targeting Technologies, Inc.. The EBRGD trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical preparations
ebrgd

General Information

Serial Number90718261
Word MarkEBRGD
Filing DateTuesday, May 18, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic radiopharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMolecular Targeting Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380

Trademark Events

Event DateEvent Description
Thursday, September 14, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 14, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 14, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 31, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 31, 2023FINAL REFUSAL E-MAILED
Wednesday, May 31, 2023FINAL REFUSAL WRITTEN
Friday, April 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION WRITTEN
Monday, August 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 12, 2022ASSIGNED TO LIE
Tuesday, July 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 7, 2022NON-FINAL ACTION E-MAILED
Monday, February 7, 2022NON-FINAL ACTION WRITTEN
Thursday, January 27, 2022ASSIGNED TO EXAMINER
Monday, August 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 21, 2021NEW APPLICATION ENTERED

Related Keywords

ebrgd preparations radiopharmaceutical diagnostic